1. Home
  2. SLDB vs MVIS Comparison

SLDB vs MVIS Comparison

Compare SLDB & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLDB
  • MVIS
  • Stock Information
  • Founded
  • SLDB 2013
  • MVIS 1993
  • Country
  • SLDB United States
  • MVIS United States
  • Employees
  • SLDB N/A
  • MVIS N/A
  • Industry
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • MVIS Industrial Machinery/Components
  • Sector
  • SLDB Health Care
  • MVIS Technology
  • Exchange
  • SLDB Nasdaq
  • MVIS Nasdaq
  • Market Cap
  • SLDB 366.2M
  • MVIS 308.8M
  • IPO Year
  • SLDB 2018
  • MVIS 1996
  • Fundamental
  • Price
  • SLDB $3.45
  • MVIS $1.19
  • Analyst Decision
  • SLDB Strong Buy
  • MVIS Buy
  • Analyst Count
  • SLDB 10
  • MVIS 4
  • Target Price
  • SLDB $18.10
  • MVIS $2.67
  • AVG Volume (30 Days)
  • SLDB 1.2M
  • MVIS 5.1M
  • Earning Date
  • SLDB 03-06-2025
  • MVIS 03-26-2025
  • Dividend Yield
  • SLDB N/A
  • MVIS N/A
  • EPS Growth
  • SLDB N/A
  • MVIS N/A
  • EPS
  • SLDB N/A
  • MVIS N/A
  • Revenue
  • SLDB N/A
  • MVIS $4,696,000.00
  • Revenue This Year
  • SLDB N/A
  • MVIS $486.46
  • Revenue Next Year
  • SLDB $717.65
  • MVIS $139.22
  • P/E Ratio
  • SLDB N/A
  • MVIS N/A
  • Revenue Growth
  • SLDB N/A
  • MVIS N/A
  • 52 Week Low
  • SLDB $2.88
  • MVIS $0.80
  • 52 Week High
  • SLDB $12.95
  • MVIS $1.95
  • Technical
  • Relative Strength Index (RSI)
  • SLDB 32.52
  • MVIS 43.82
  • Support Level
  • SLDB $4.12
  • MVIS $1.15
  • Resistance Level
  • SLDB $4.44
  • MVIS $1.69
  • Average True Range (ATR)
  • SLDB 0.37
  • MVIS 0.13
  • MACD
  • SLDB -0.20
  • MVIS -0.01
  • Stochastic Oscillator
  • SLDB 0.87
  • MVIS 19.35

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

About MVIS MicroVision Inc.

Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.

Share on Social Networks: